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During EBV-associated IM IAV-specific crossreactive memory T cells are 
activated and play a role in disease severity. In HLA-A2+ IM patients, influenza 
M158 (IAV-M1)-specific CD8 memory T cell responses crossreacted with two 
different EBV lytic epitopes, BMLF1280 (17/29) and BRLF1190 (19/20). 
Furthermore, 11/22 IM patients demonstrated some intra-viral crossreactivity 
between EBV-BRLF1 and -BMLF1 responses. Disease severity of IM directly 
correlated with significantly increased frequencies of crossreactive IAV-M1/EBV-
BMLF1, IAV-M1, and EBV-BMLF1 specific CD8 cells, and with mean viral load 
over the first 5 weeks of infection. Disease severity did not correlate with BRLF1 
or M1/BRLF1 crossreactive responses. When severity of IM was scored and 
patients were assigned to either mild or severe groups, disease severity 
correlated with specific TCR Vb usage in IAV-M1 population suggesting that TcR 
selection is driving disease outcome. Consistent with IAV-M1 and EBV-BMLF1 
responses driving increased immunopathology was the observation that patients 
with severe disease had significantly more IAV-M1 and EBV-BMLF1 cells 
producing IFNg/MIP1-b in response to antigen as compared to patients with mild 
disease. These results suggest that T cell crossreactivity impacts T cell selection 
and function and ultimately disease outcome. Insights on these issues are 
important for the intelligent design of vaccines and to develop therapeutic 
interventions for virally induced disease (NIHAI49320).  
  
